Results 321 to 330 of about 467,609 (357)
Some of the next articles are maybe not open access.

Acute myeloid leukemia in adults

Current Treatment Options in Oncology, 2000
The treatment outcome for most adults with acute myeloid leukemia (AML) remains unacceptable. Additional agents or substitution of high-dose cytarabine for conventional-dose cytarabine during induction does not improve the remission rate or overall survival. There is substantial toxicity with high-dose cytarabine during induction.
L D, Cripe, S, Hinton
openaire   +2 more sources

Chronic myeloid leukemia transformation into acute myeloid leukemia

Indonesian Journal of Biomedicine and Clinical Sciences
Chronic myeloid leukemia (CML) is a myeloproliferative disorder characterized by excessive accumulation of apparently normal myeloid cells and the Philadelphia chromosome resulting from t(9;22) reciprocal chromosomal translocation and leading to BCR-ABL fusion gene formation.
null Nugra Akzatama   +1 more
openaire   +1 more source

Acute Myeloid Leukemia

New England Journal of Medicine, 1999
Löwenberg, Bob, Downing, JR, Burnett, A
openaire   +3 more sources

Acute Myeloid Leukemia

New England Journal of Medicine, 2015
Hartmut, Döhner   +2 more
openaire   +2 more sources

Chronic myeloid leukemia

The American Journal of Medicine, 1986
R T, Silver, R P, Gale
openaire   +2 more sources

Fitness landscapes and the myeloid leukemias

Leukemia Research, 1999
Fitness landscapes, which provide a unique perspective for viewing co-evolving cell populations, were used to study the evolution of CML and MDS. This led to several conclusions: (1) accelerated phase CML and RAEB/RAEBt are not specific disease entities.
openaire   +2 more sources

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen   +2 more
exaly  

Chronic Myeloid Leukemia

Emerging Cancer Therapeutics, 2010
Elias Jabbour   +2 more
openaire   +1 more source

Venetoclax in acute myeloid leukemia

Expert Opinion on Investigational Drugs, 2023
Bruzzese, Antonella   +8 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy